Bidirectional Mendelian Randomization and Colocalization Study of Memory B Cells and Major Depressive Disorder

Area of Science:

• Immunology
• Psychiatry
• Genetics

Background:

• Neuroinflammation is implicated in major depressive disorder (MDD) pathogenesis.
• The specific role of memory B cells in MDD remains largely unexplored.
• Investigating immune cell contributions is crucial for understanding MDD etiology.

Purpose of the Study:

• To investigate the potential causal relationship between memory B-cell traits and major depressive disorder (MDD) risk.
• To explore bidirectional causal links using Mendelian randomization (MR) and colocalization analyses.
• To identify potential immune-related biomarkers for MDD.

Main Methods:

• A bidirectional two-sample Mendelian randomization (MR) study was performed.
• Genome-wide association study (GWAS) data for MDD and immune phenotypes were utilized.
• Bayesian colocalization and sensitivity analyses were conducted to ensure result validity.

Main Results:

• Genetically predicted higher CD27 protein expression on memory B cells was associated with an increased risk of MDD (ORs: 1.025-1.063, P_FDR < 0.05).
• No evidence of a causal effect of MDD on memory B-cell traits was found.
• Colocalization analyses indicated distinct genetic loci, suggesting separate biological pathways.

Conclusions:

• CD27 protein expression on memory B cells may represent a novel causal factor in MDD development.
• These findings suggest CD27 as a potential biomarker for MDD.
• Further clinical research is warranted to validate CD27 as a therapeutic target for MDD.